<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03580772</url>
  </required_header>
  <id_info>
    <org_study_id>IRAS241978</org_study_id>
    <nct_id>NCT03580772</nct_id>
  </id_info>
  <brief_title>Persona MC vs Attune Total Knee Replacement Study</brief_title>
  <acronym>PERTUNE</acronym>
  <official_title>Functional Comparison of Two Modern Designs of Total Knee Replacement - a Post-operative Comparator Gait Study Comparing Persona MC to Attune Total Knee Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leeds</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Leeds</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare clinical and functional outcomes of a cohort of patients that have
      undergone a medial congruent TKR to a similar cohort of patients that have undergone a
      conventional TKR and a cohort of control participants. Our null hypothesis is that there will
      be no difference in the functional outcome (as assessed by gait analysis) between Attune and
      Persona MC TKR.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This cross sectional, post-operative comparator gait study aims to compare the functional and
      patient reported outcomes of patients that have undergone a MC TKR to an age, gender, BMI,
      pre-operative diagnosis with satisfactory clinical outcome at one year (OKS &gt; 34) matched
      cohort of patients undergone a modern generation TKR which utilises a gradually reducing
      radius of curvature on the femoral component with conventional polyethylene (Attune) to a TKR
      with gradually reducing radius of curvature on the femoral component but a medial congruent
      (MC) TKR design (Persona).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 26, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Knee extensor moment</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>Maximum knee extensor moment during stair descent of the operated limb</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients able to complete each gait assessment</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>During level walking and stair ascent/descent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait velocity</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>During level walking and stair ascent/descent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stance time</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>During level walking and stair ascent/descent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee flexion-extension range of motion</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>During level walking, stair ascent/descent and sit to stand</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee extension moments</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>During level walking, stair ascent and sit to stand</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee adduction moment</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>During level walking and stair ascent/descent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ground reaction forces</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>During level walking and stair ascent/descent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sit to stand time</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>During a sit to stand task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee angular velocity</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>During a sit to stand task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total OKS</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>Total score, OKS function subscale and OKS pain subscale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2011 Knee Society Objective Knee Score</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>Post-operative knee function and overall health assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Euro-QoL 5D (EQ-5D) index</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>Quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forgotten Joint Score</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>The Forgotten Joint Score is a 12-item questionnaire completed by the patient to determine how aware they are of their joint in their everyday life.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient demographics</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>age at surgery (yrs), gender (male/female), BMI</description>
  </other_outcome>
  <other_outcome>
    <measure>Pre-operative diagnosis</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>osteoarthritis /avascular necrosis</description>
  </other_outcome>
  <other_outcome>
    <measure>ASA grade</measure>
    <time_frame>Average 3 years ± 2 years post-surgery</time_frame>
    <description>1/2/3</description>
  </other_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Persona TKR</arm_group_label>
    <description>Patients will have undergone a medial congruent Persona total knee replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Attune TKR</arm_group_label>
    <description>Patients will have undergone a Attune total knee replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control participants</arm_group_label>
    <description>Patients will not have recieved a primary TKR</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Persona TKR</intervention_name>
    <description>Persona® TKR (Zimmer Biomet)</description>
    <arm_group_label>Persona TKR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Attune TKR</intervention_name>
    <description>Attune® TKR (Depuy synthes)</description>
    <arm_group_label>Attune TKR</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Potential patients that have undergone either a medial congruent Persona TKR or Attune TKR
        will be identified by the relevant orthopaedic surgeon. Control participants will be
        identified from an established database.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged 18 years and above*

          2. Have undergone primary total knee replacement for either:

               1. Osteoarthritis

               2. avascular necrosis of the femur or tibia

          3. Report an Oxford Knee Score greater than 34, obtained from usual clinical practice.
             OKS above 34 represents (range 0-48, high representing good outcome) a good outcome
             post-surgery.

          4. Independent of study participation, patients received either commercially available
             Zimmer Biomet Persona MC bearing or DePuy Synthes Attune knee implants implanted in
             accordance with product labelling

          5. 1-5 years post TKR surgery

          6. An adequate understanding of written and verbal information in English in order to
             provide informed consent and answer the study questionnaires* * Control participants
             will meet same inclusion criteria except no primary TKR and OKS will not be required

        Exclusion Criteria:

          1. History of infection in the replaced joint and/or other local/systemic infection that
             may affect the prosthetic joint

          2. Skeletal immaturity

          3. Neuropathic arthropathy

          4. Osteoporosis/any loss of musculature or neuromuscular disease that compromises the
             affected limb

          5. Severe instability secondary to the absence of collateral ligament integrity

          6. Pregnancy - routine clinical practice ensures that all female patients are asked
             whether they are pregnant and can safely receive x-rays or surgery as per standard
             consent forms

          7. Patient is a member of a protected population (e.g., prisoner, mentally incompetent,
             etc.)

          8. Patient has previously received partial or total knee arthroplasty for the ipsilateral
             knee

          9. Patients who are unable to give voluntary informed consent.

         10. Patients who are unable to walk unaided (post-surgery).

         11. BMI &gt; 40

             ** Control participants will meet the same exclusion criteria as TKR patients

         12. Patients who suffer with cognitive impairment such as Parkinson's or Alzheimer's
             disease resulting in impaired mental capacity.

         13. Patients who are unable to walk unaided.

         14. Patients who suffer from dizzy spells or fainting episodes.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hemant Pandit, MBBS, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Leeds</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hemant Pandit, MBBS, MS</last_name>
    <phone>+44 113 392 4883</phone>
    <email>h.pandit@leeds.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Graham Chapman, PhD</last_name>
    <phone>+44 113 3924920</phone>
    <email>g.j.chapman@leeds.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chapel Allerton Hospital</name>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hemant Pandit, Prof</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>June 5, 2018</study_first_submitted>
  <study_first_submitted_qc>June 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2018</study_first_posted>
  <last_update_submitted>November 30, 2018</last_update_submitted>
  <last_update_submitted_qc>November 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leeds</investigator_affiliation>
    <investigator_full_name>Hemant Pandit</investigator_full_name>
    <investigator_title>Professor of Orthopaedic Surgery</investigator_title>
  </responsible_party>
  <keyword>Total knee replacement</keyword>
  <keyword>Total knee arthroplasty</keyword>
  <keyword>Gait analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Non-identifiable data from those patients that have undergone the MC TKR surgery will be transferred to the research funder, who will combine this with data from another trial (POLAR) for analysis.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Data will be available at the end of the study and will be available for three years</ipd_time_frame>
    <ipd_access_criteria>Patient identifiable information will not be shared with the funder. Other relevant information will be shared after completing the study and analysing the data</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

